High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome
Top Cited Papers
- 1 March 2006
- journal article
- clinical trial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (3) , 542-549
- https://doi.org/10.1111/j.1538-7836.2005.01751.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary InterventionCirculation, 2005
- Variability in platelet responsiveness to clopidogrel among 544 individualsJournal of the American College of Cardiology, 2005
- The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart diseaseThrombosis and Haemostasis, 2005
- Platelet Receptors for Adenine Nucleotides and Thromboxane A2Seminars in Thrombosis and Hemostasis, 2004
- Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial InfarctionCirculation, 2004
- Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterizationThe American Journal of Cardiology, 2004
- Clopidogrel for Coronary StentingCirculation, 2003
- Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placementHeart, 2001
- The P2Y 12 receptor as a therapeutic target in cardiovascular diseasePlatelets, 2001
- The in vivo pharmacological profile of CS‐747, a novel antiplatelet agent with platelet ADP receptor antagonist propertiesBritish Journal of Pharmacology, 2000